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Thrombus in Patients Undergoing Catheter
Ablation of Atrial Fibrillation
Matthew W. Martinez, MD, Jacobo Kirsch, MD, Eric E. Williamson, MD, Imran S. Syed, MD,
DaLi Feng, MD, Steve Ommen, MD, Douglas L. Packer, MD, Peter A. Brady, MD, FRCP
Rochester, Minnesota
O B J E C T I V E S The aim of this study was to determine whether multidetector computed tomogra-
phy (MDCT) is able to exclude left atrial appendage (LAA) thrombus in patients referred for catheter
ablation of atrial ﬁbrillation (CAAF).
B A C KG ROUND MDCT is commonly used to render pulmonary vein and left atrial anatomy before
CAAF. Transesophageal echocardiography (TEE) is also often performed before the ablation to exclude
LAA thrombus. Whether MDCT alone is sufﬁcient to exclude LAA thrombus is unknown.
METHOD S Patients referred for CAAF at the Mayo Clinic between March 2004 and October 2006
were included. Clinical data, 64-slice MDCT (nonelectrocardiography-gated), and TEE were all analyzed.
Image data were independently reviewed by 2 cardiac radiologists blinded to the TEE ﬁndings. The
appearance of the LAA was deﬁned as normal (fully opaciﬁed) or abnormal (underﬁlled).
R E S U L T S Four hundred two patients (mean age 56  10 years; 76% male; ejection fraction 56 
10%) were included. Three hundred sixty-two had no evidence of a ﬁlling defect by ungated MDCT or
left atrial spontaneous echo contrast or thrombus by TEE. In 40 patients, the LAA was “underﬁlled” with
9 deﬁnite thrombi conﬁrmed by TEE. Sensitivity and speciﬁcity was 100% and 92%, respectively, with a
negative predictive value of 100% and positive predictive value of 23%. In patients with LAA underﬁlling,
Doppler-derived LAA emptying velocities were substantially reduced (mean 19 cm/s; range 6 to 61 cm/s)
below the normal range. A higher CHADS2 (congestive heart failure, hypertension, age older than 75
years, and diabetes) score (1.6 vs. 1.1) was observed in patients with LAA ﬁlling defects. No cases of LAA
thrombus were observed in patients age 52 years with CHADS2 score 1.
CONC L U S I O N S In patients referred for CAAF, MDCT is a sensitive (100% sensitivity) imaging
modality that could be used alone especially in patients age 52 years with a CHADS2 score 1.
Incorporation of these ﬁndings could decrease the need for multiple imaging modalities and thereby
reduce cost of the procedure. (J Am Coll Cardiol Img 2009;2:69–76) © 2009 by the American College
of Cardiology Foundation
From the Division of Cardiovascular Diseases and Department of Radiology, Mayo Clinic, Rochester, Minnesota.Manuscript received June 20, 2008; revised manuscript received September 25, 2008, accepted September 30, 2008.
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70atheter ablation within the left atrium is
increasingly used as a therapeutic option
for patients with symptomatic atrial fibril-
lation (AF) (1). Imaging of the heart and
ntrathoracic structures before the ablative proce-
ure by computed tomography (CT), cardiac mag-
etic resonance, or transesophageal echocardiogra-
hy (TEE) might be useful in planning the
rocedure, because it allows identification of the
umber and topology of the pulmonary veins as well
See page 77
s the relationship of the left atrium to proximate
horacic structures, in particular the esophagus. In
ddition, pre-acquired CT and cardiac magnetic
resonance images might be integrated
with advanced 3-dimensional electroana-
tomic mapping systems to assist in map-
ping and ablation (2) and during
follow-up for detection of complications
such as pulmonary vein stenosis (3). Be-
cause patients with AF are at increased
risk of stroke from a left atrial (LA)
thrombus (4) most commonly from within
the left atrial appendage (LAA), (5) pre-
operative imaging of the left atrium and
appendage is also necessary to exclude the
presence of a mass or thrombus before
instrumentation of the left atrium. In cur-
rent clinical practice TEE is considered to
be the “gold standard” imaging tool and is
performed in most cases within 24 to 48 h
of the procedure to exclude LAA throm-
bus. However, TEE requires moderate
sedation and esophageal intubation and
might not allow complete visualization
and assessment of all of the pulmonary
eins nor their precise relationship to other thoracic
tructures. Additionally, TEE imaging is not gen-
rally useful during the ablative procedure. Thus,
efore a catheter ablation procedure for AF patients
requently undergo evaluation with multiple imag-
ng modalities, increasing the potential for compli-
ations not directly related to the ablative procedure
s well as increasing cost of the procedure.
Multidetector computed tomography (MDCT)
s a widely available and reproducible imaging
echnique that can quickly, accurately, and nonin-
asively determine pulmonary vein and LA anat-
my in addition to providing accurate data regard-
ng their relationship to other thoracic structures. In
der
ackddition, MDCT allows excellent visualization of ohe LAA and might be useful in excluding LAA
hrombus. Prior studies have investigated various
enerations of CT scanners, including electron
eam CT and different iterations of MDCT scan-
ers (6–13). However, sensitivity and specificity of
ated MDCT in excluding LAA thrombus has
aried in prior studies, and there have been no
tudies published to evaluate the utility of ungated
DCT for assessment of LAA thrombus. In ad-
ition, few have used only 64 MDCT in a homog-
nous study population with a uniform protocol for
ll study participants.
To determine this, we sought to compare the
ensitivity and specificity of MDCT with TEE in
xcluding an LAA thrombus in patients before
atheter ablation of AF.
ETHODS
atient population. The study included all consecu-
ive patients referred to the Mayo Clinic between
arch 2004 and October 2006 for LA catheter
blation of symptomatic AF who completed preop-
rative screening and evaluation. Clinical charac-
eristics of the study population are summarized
Table 1).
re-AF ablation imaging. Before catheter ablation all
atients underwent imaging of the left atrium and
ppendage with ungated MDCT and TEE to
etermine the number and topology of the pulmo-
ary veins and exclude intracardiac mass or throm-
us. In most cases, MDCT was performed on the
ay before the procedure; TEE was performed
ither the day before or the day of the ablation
rocedure. To account for the possibility of clot
evelopment between studies, only patients who
nderwent a pre-ablation CT and TEE within 3
ays of one another were included.
T scanning. Ungated contrast-enhanced CT of the
hest was performed with a 64-slice CT scanner
Siemens Medical Solutions, Forchheim, Germany)
ith a standardized protocol that has been de-
cribed previously (3). In brief, a bolus of 150 ml of
odinated contrast media with a concentration of
00 mgI/ml (Iohexol/Omnipaque 300, GE Health-
are, Milwaukee, Wisconsin) was injected intrave-
ously at an injection rate of 4 ml/s. After injection,
here was a 5-s delay before the monitoring scan
egan in the ascending aorta. Images were then
btained every 2 s until the necessary threshold was
chieved (up to 10 s to complete). Once the signal
n the ascending aorta reached a predefined thresh-B B R E V I A T I O N S
N D A C R O N YM S
F atrial fibrillation
AAF catheter ablation of
trial fibrillation
HADS2 congestive heart
ailure, hypertension, age ol
han 75 years, and diabetes
I confidence interval
T computed tomography
A left atrial
AA left atrial appendage
DCTmultidetector
omputed tomography
R odds ratio
EC spontaneous echo
ontrast
EE transesophageal
chocardiographyld of 150 HU, automated breath-hold instructions
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71ere given and the table moved into position to
can, typically 5 s in total to complete before the
can was initiated. The entire volume of the heart
as then scanned during 1 breath-hold at expira-
ion in 15 to 20 s. The entire process from injection
o complete scanning of the heart took approxi-
ately 40 s. No adjustments to the scans on the
asis of left atrium or LAA opacification were
erformed. Detector collimation was 64  0.6 mm,
antry rotation speed was 330 ms/rotation, pitch
as 1.1, and tube voltage was 120 kVp with a
ariable tube current set at a quality reference of 850
As. Reconstructions were performed with a B40f
ernel to generate 1.5-mm-thick slices with a
econstruction interval of 0.6 mm with a medium
eld of view (300 mm) centered at the heart. This
roduced an axial set of 300 to 400 images for
eview with an Advantage workstation or Vitrea
orkstation. This was the standard protocol, recon-
truction, and method of evaluation at our institu-
ion for pre-ablation MDCT imaging.
All images were acquired in the supine position and
eviewed independently by 2 experienced cardiac ra-
iologists who were blinded to the results of the TEE.
o attempt was made to “optimize” imaging of the
AA. All images were reviewed simultaneously by
oth cardiac radiologists, and final interpretation in all
ases was agreed upon by consensus.
The LAA was reported as either “normal” if the
ntire LAA was filled with contrast and fully
pacified (Fig. 1A) or as abnormal and “under-
Table 1. Patient Population Demographic Data
No Thrombus (n 
Male, n (%) 278 (77)
Female, n (%) 84 (23)
Age (yrs), mean (SD) 56 10
Mean ejection fraction, % (SD) 56 10
Persistent atrial ﬁbrillation, n (%) 210 (58)
Paroxysmal atrial ﬁbrillation, n (%) 152 (42)
Anticoagulation therapy, n (%) 265 (73)
Antiplatelet therapy, n (%) 191 (53)
Stroke risk factors
Hypertension, n (%) 203 (56)
Diabetes mellitus, n (%) 25 (7)
Prior CVA/TIA, n (%) 14 (4)
LV dysfunction/CHF, n (%) 59 (16)
Age 65 yrs, n (%) 73 (20)
Mean CHADS2 score 1.1
n  402. All study participant demographic data divided by normal or underﬁlle
variables and CHADS2 score.
CHADS2  congestive heart failure, hypertension, age older than 75 yea
accident/transient ischemic attack; LAA  left atrial appendage; LV  left ventlled” if there was any difficulty visualizing the tAA due to not being fully opacified with contrast
edia (Fig. 1B). If the interpreting physician was
nable to visualize the entire LAA filled with
ontrast, the appendage was considered underfilled
nd abnormal. With this method, any difficulty
iewing the entire LAA was considered abnormal.
ll images were viewed in the axial plane only
ithout the use of multi-planar reconstructions
MPR) or 3-dimensional volume rendering views.
he use of “delayed” imaging of an underfilled
AA was not used for this study. Differences in the
attern or extent of the LAA filling defects were
ot systematically reported or compared with TEE.
EE. Transesophageal echocardiography was per-
ormed with a 3.5- to 7-MHz multiplane probe
ositioned at the appropriate level within the
sophagus. Imaging was focused on each of the
ulmonary veins, and when possible Doppler veloc-
ties were measured. For the LA and LAA multiple
iews were recorded along with a “sweeping” view
o optimize visualization of the entire structure with
careful search for the presence of thrombus within
he LA or LAA. All images were interpreted by 2
chocardiographers blinded to the results of the
T. In cases where a pulsed wave Doppler signal
as obtained at the mouth of the LAA, all the
oppler values were averaged and recorded. A
efinite thrombus was said to be present if an
cho-dense material acoustically separate from the
ndocardium was found within the LA or LAA. No
cho contrast agents were used in any of the TEEs
2) LAA Underﬁlled (n  40) p Value
30 (75) NS
10 (25)
59 10 NS
55 10 NS
29 (73) 0.08
11 (27)
33 (83) 0.20
16 (40) 0.13
31 (78) 0.009
4 (10) NS
3 (8) NS
15 (38) 0.001
7 (18) NS
1.6 0.004
gated multi-detector computed tomography (MDCT) ﬁndings including clinical
nd diabetes; CHF  congestive heart failure; CVA/TIA  cerebrovascular
r.36
d un
rs, ao identify thrombus within the LAA. The LAA in
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72ach study was graded as none, mild spontaneous
cho contrast (SEC), moderate SEC, severe SEC,
r as thrombus on the basis of previous descriptions
9,14). The finding of moderate SEC or above was
onsidered as abnormal.
hrombus risk. Risk factors for stroke in AF on the
asis of the CHADS2 scoring system (15–17)
Normal LAA by MDCT and TEE
age by multidetector computed tomography (MDCT) demon-
mplete opaciﬁcation of the left atrial appendage (arrow) consid-
al” without thrombus. (B) Transesophageal echocardiographic
e of the left atrial appendage (LAA) in the same patient demon-
normal LAA without thrombus or moderate/severe spontaneous
ast.hereby 1 point is given for each risk factor wcongestive heart failure, hypertension, age older
han 75 years, and diabetes) and 2 points for a
istory of transient ischemic attack (TIA) or prior
troke were used to determine clinical stroke risk.
se of anticoagulation with warfarin or low molec-
lar weight heparin was based upon stroke risk
ssessment by the referring physician. In all cases,
arfarin was discontinued at least 2 days before the
blation procedure, most often the day before
DCT or TEE. The decision to use bridging
herapy with heparin while off warfarin was based
pon clinical risk assessment or the presence of
rosthetic heart valves and the like. The number of
atients receiving oral anticoagulation and/or anti-
latelet therapy before the initial imaging study
either MDCT or TEE) was recorded.
All clinical and imaging data were entered into a
entralized database prospectively and analyzed ret-
ospectively.
tatistical analysis. Logistic regression analysis was
erformed to assess the association between abnor-
al filling in the LAA and CHADS2 score. The
HADS2 score was used as a single variable (the
core value) to look for prediction of an abnormal
lling defect. Categorical comparisons between
roups were completed with chi-square test for
ndependence. Continuous variables were compared
ith Wilcoxon rank-sum tests. All data were re-
iewed in a manner consistent with Mayo Clinic
nstitutional Review Board requirements.
E SULTS
tudy population. Between March 2004 and Octo-
er 2006, a total of 402 consecutive patients who
ere referred for LA ablation because of symptom-
tic AF underwent complete clinical assessment and
re-ablation imaging with ungated MDCT and
EE and comprised the study population. Patients
ithout evidence of intracardiac thrombus under-
ent subsequent LA ablation with either an ostial
ircumferential pulmonary vein or wider area ap-
roach incorporating linear ablation guided by elec-
roanatomic mapping (1). Patients were of mean
ge 56  10 years with ejection fraction of 56 
0% and were mostly male (76%) with more than
ne-half (59%) in AF at the time of clinical assess-
ent and imaging (persistent clinical pattern).
haracteristics of the study population are summa-
ized in Table 1 and presented according to the
resence or absence of LAA filling defect observed
ith ungated MDCT. Almost three-quarters (74%)Figure 1.
(A) Axial im
strating co
ered “norm
(TEE) imag
strating aere therapeutically anticoagulated with warfarin
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73efore and during pre-operative evaluation per
sual guidelines (1), which was discontinued just
efore the ablative procedure, as is our current
ractice.
iming of pre-ablation imaging. In all cases, imaging
ith MDCT and TEE was performed within 72 h
f each other and within 24 h in 57% of cases.
DCT. The LAA by ungated MDCT was reported
s normal and without filling defect in 362 of 402
atients (90%) and abnormal or “under-filled” due
o incomplete filling of the LAA with contrast in 40
atients (10%). In 9 of the 40 patients in whom a
lling defect within the LAA was reported, further
valuation by TEE confirmed the presence of
hrombus within the LAA (Figs. 2A and 2B).
ransesophageal imaging. Pre-ablation TEE was
eported as normal (without definite thrombus or
vidence of moderate to severe SEC) in each of the
62 patients reported as having a normal LAA by
ngated MDCT. Of the remaining 40 patients in
hom underfilling of the LAA was present by
ngated MDCT, TEE was found to be abnormal
n all cases. In 78% (31 of 40) of these, at least
oderate SEC but without clear identifiable
hrombus was present. In the remaining 9 patients,
n addition to SEC, a definite thrombus was present
y TEE (9 of 401 or 2.2%; 100% sensitivity for
etection of LAA thrombus).
linical characteristics of patients with “under-ﬁlled”
AA. To determine whether clinical risk factors for
troke in AF impacted the findings on pre-ablation
maging, a CHADS2 score was calculated for each
atient and analyzed according to the presence or
bsence of a filling defect (Table 2). The most
ommon cardiovascular risk factor for thromboem-
olism on the basis of the CHADS2 score was
ypertension (58%) followed by congestive heart
ailure (18%), diabetes mellitus (7%), and prior
istory of cerebrovascular accident/TIA (4%). The
HADS2 score was lower in patients without
vidence of LAA underfilling when compared with
hose with underfilling of the LAA (1.1 vs. 1.6,
espectively, p  0.004) and was mostly due to the
reater prevalence of hypertension and congestive
eart failure in patients with abnormal LAA find-
ngs. No differences were apparent in age, gender,
r left ventricular ejection fraction variables be-
ween those patients with definite thrombus or
nderfilling of the LAA and those without these
ndings. Patients with underfilling of the LAA by
ngated MDCT were more likely to have a persis-
ent rather than a paroxysmal pattern of AF (73%
s. 58%, p  0.08) and were more likely to haveeduced emptying velocity of the LAA by Doppler
nterrogation when compared with those without
nderfilling or thrombus within the LAA (19 cm/s
Figure 2. Underﬁlled LAA by MDCT and TEE Showing Evidence
Thrombus
(A) Axial image by MDCT demonstrating underﬁlled or “abnormal”
failure of contrast to ﬁll the LAA (arrow). (B) Transesophageal echo
graphic image in the same patient demonstrating obvious thrombu
within the LAA (arrow). Abbreviations as in Figure 1.
Table 2. Patient Demographic Data CHADS2 Score Values
CHADS2 Score MDCT TEE MDCT TEE MDC
0 0 5
1 3 14
2 2 9
3 1 3
4 3 0
CHADS2 score ﬁndings based on normal or underﬁlled ungated ﬁndings.of LAA
LAA with
cardio-
s presentT TEE
120
135
78
22
7Abbreviations as in Table 1.
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74s. “normal” of 45 cm/s) (5,6). With a regression
odel, only the presence of congestive heart failure
odds ratio [OR]: 3.0; 95% confidence interval
CI]: 1.5 to 6.2, p  0.001) and hypertension (OR:
.7; 95% CI: 1.3 to 6.2; p  0.001) were predictive
f LAA underfilling, whereas AF duration, age,
ender, or prior cerebrovascular accident/TIA or
iabetes mellitus were not predictive. As a com-
ined predictor, for each 1-point increase in the
HADS2 score, an increase in the OR of 1.5 was
bserved (p  0.001; 95% CI: 1.2 to 2.0). No
atients 52 years of age with a CHADS2 score
1 were found to have LAA thrombus.
In those with a filling defect and confirmed
hrombus by TEE there were notable differences.
he CHADS2 score was significantly higher in
hose patients with a definite thrombus when com-
ared with those without any filling defect (2.4 vs.
.1, p  0.004), with most patients having a
iagnosis of hypertension. In addition, most (78%)
ere older than 65 years with a history of congestive
eart failure or ejection fraction of 50% in more
han one-half (56%). All were in persistent AF and
nticoagulated with a therapeutic international nor-
alized ratio at the time of the evaluation with
ngated MDCT and TEE.
I SCUS S ION
he most important finding of this study is that, in
atients with symptomatic AF referred for LA cath-
ter ablation, the sensitivity and specificity of ungated
DCT for excluding LAA thrombus and for detec-
ion of features associated with LAA thrombus when
ompared with TEE is high. In all cases, abnormali-
ies of the LAA observed with ungated MDCT were
ssociated with either definite LAA thrombus or
igh-risk features such as moderate to severe SEC at
he time of TEE. Specifically, in each of the 40 cases
here ungatedMDCT reported a filling defect within
he LAA, the LAA was also abnormal by TEE, with
t least moderate SEC being present in 31 patients
nd definite thrombus present in 9 patients (sensitivity
f CT for detection of thrombus  100%, specificity
92%, negative predictive value  100%, positive
redictive value  23%). A second finding was that
he prevalence of LAA thrombus in this population is
ow. The most important clinical predictors of the
resence of an LAA thrombus were history of con-
estive heart failure and hypertension. Therapeutic
nticoagulation with warfarin before catheter ablation
id not definitely rule out the presence of intracardiac
hrombus. Taken together, these findings suggest that vngated MDCT, in addition to providing accurate
natomic rendering of the left atrium and pulmonary
eins before catheter ablation in patients with AF,
ight also be a useful tool to exclude the presence of
AA thrombus. This would allow one to avoid
ultiple imaging modalities before LA ablation,
hereby reducing the cost of the procedure.
Although the specificity of MDCT to detect the
resence of a definite thrombus was not 100% in
his study, all patients who were subsequently found
o have an LAA abnormality, such as moderate to
evere SEC or definite thrombus, were reliably
dentified by MDCT (sensitivity 100%). This is
mportant, because although ungated MDCT could
ot visually distinguish SEC from definite throm-
us (i.e., reduced specificity), all such patients
ould in any case require further evaluation to
xclude LAA abnormality and would therefore
ost likely undergo TEE. Further assessment with
elayed imaging of the LAA at 1 to 2 min might
lso improve the specificity for distinguishing SEC
rom thrombus (10). Further investigation of a
arger population of patients with underfilled LAA
or differentiation of SEC and thrombus might
mprove the positive predictive value and specificity.
owever, patients with underfilling of the LAA
epresent only a small proportion of individuals
eferred for catheter ablation. Thus, a normal un-
ated MDCT, especially in patients at low clinical
isk for thrombus in the setting of AF (i.e.,
HADS2 score 2), would obviate the need for
dditional TEE in 90% of patients, leading to
ignificant cost savings.
Previous studies have evaluated the efficacy of
T to identify LA and LAA thrombus but were
imited by small numbers of patients and use of
arlier generation scanners with lower spatial and
emporal resolution and employed a variety of
canning protocols (6,8–10). In contrast, our study
eports on a large cohort evaluated by a standard-
zed scanning technique, protocol, and operators,
llowing a more robust assessment of the efficacy of
ngated MDCT in excluding LAA abnormality.
dditionally, our methods relied only on a visual
ssessment of the LAA rather than a more cum-
ersome quantitative assessment of contrast density
atios with Hounsfield units. Differentiation be-
ween moderate/severe SEC and true thrombus is
ore difficult and could not be achieved reliably by
isual assessment alone in this study. However, the
urpose of this study was not to prove that MDCT
as superior to TEE in identification of SEC
ersus formed thrombus but rather the sensitivity of
u
t
d
c
s
a
m
p
M
M
M
r
b
a
c
c
p
1
c
t
a
i
r
S
T
w
a
d
s
c
u
t
i
w
t
d
s
i
m
w
g
s
L
a
s
w
p
t
C
I
n
7
a
f
L
s
b
b
t
p
p
C
M
i
w
w
p
a
p
R
M
S
R
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 1 , 2 0 0 9
J A N U A R Y 2 0 0 9 : 6 9 – 7 6
Martinez et al.
MDCT for Excluding Thrombus Before AF Ablation
75ngated MDCT in identifying an abnormal LAA
hat would prompt further evaluation. Whether
ifferent scanning protocols or patient positioning
ould increase specificity of ungated MDCT de-
erves further study.
Unsurprisingly, increasing CHADS2 score was
ssociated with an abnormal LAA by MDCT with
arked differences in CHADS2 score between
atients with an LAA thrombus confirmed by
DCT and TEE versus those with a positive
DCT and negative TEE and those with a normal
DCT (CHADS2 score of 2.4, 1.6, and 1.1,
espectively). Of note, in our study, an LAA throm-
us was not observed in any patient 52 years of
ge with a CHADS2 score of 1. However, in-
reasing CHADS2 score was associated with in-
reased likelihood of LAA thrombus, with each
oint increasing the odds of an LAA thrombus by
.5 times. Last, the finding that all 9 patients with
onfirmed LAA thrombus were therapeutically an-
icoagulated with warfarin just before evaluation
rgues for appropriate imaging of the LAA in most
f not all patients before catheter ablation of AF,
egardless of anticoagulation history.
tudy limitations. One limitation of our study is that
EE was considered the “gold standard” against
hich MDCT was judged, and the presence or
bsence of LAA thrombus was not confirmed by
irect visual inspection of anatomic or surgical
pecimens. Thus, cases of merely “severe” SEC
ould have hidden a formed thrombus that was
ndiagnosed by TEE. Despite this, our conclusion
hat MDCT is a sensitive (rather than specific) tool
s valid, because the important clinical question is
hether further evaluation is needed on the basis of
he MDCT findings. A second limitation is that we
id not attempt to “optimize” imaging of the LAA,
uch as patient positioning, or compare with othergrated electroanatomic mapping with 2002;13:764–7.ight favorably alter the specificity of MDCT
hen compared with TEE. However, the use of
ated MDCT data would increase radiation expo-
ure to the patient and therefore is less desirable.
ast, although the majority of images from MDCT
nd TEE were obtained within 48 h of one another
uch that the risk of “new” thrombus formation
ould be low, we cannot entirely rule out the
ossibility that this did occur between studies,
hereby altering our findings.
ONCLUS IONS
n patients referred for catheter ablation of AF,
oninvasive imaging with ungated MDCT within
2 h of the ablation, in addition to providing useful
natomic data, is a sensitive (100% sensitivity) and
airly specific (92% specificity) imaging modality for
AA thrombus assessment that could be used as a
tand-alone evaluation in most patients. On the
asis of these findings a reasonable approach would
e for “low-risk” patients, on the basis of CHADS2,
o undergo MDCT alone, with further imaging
erformed only if underfilling of the LAA was
resent. In contrast, older patients with a higher
HADS2 score would undergo evaluation by both
DCT and TEE or intraoperative imaging with
ntracardiac echocardiography before proceeding
ith transseptal access to the left atrium. This
ould reduce the need for multiple imaging in the
reoperative assessment in patients sent for LAA
blation, significantly reducing costs of the
rocedure.
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